Clinical Trial Update: Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of topical tofacitinib for alopecia areata and its variants (alopecia totalis and alopecia universalis) has res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata
• Alopecia Totalis
• Alopecia Universalis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Yale University | Conditions: Alopecia Areata, Alopecia Totalis | Phase 2 | Status: COMPLETED | Results posted: 2018-10-10